Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
Status:
Active, not recruiting
Trial end date:
2023-04-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of oral deucravacitinib in
participants with moderate to severe ulcerative colitis (UC).